A Case Study of Pleuroparenchymal Fibroelastosis Exhibiting No Radiological Evidence of Pleural Involvement - Report - MDSpire

A Case Study of Pleuroparenchymal Fibroelastosis Exhibiting No Radiological Evidence of Pleural Involvement

  • By

  • Iris A. Simons

  • Daniel A. Korevaar

  • Teodora Radonic

  • Carmen Ariño-Palao

  • Ralf W. Sprengers

  • Martijn van Dorp

  • Marjolein E. M. Lacor

  • JanWillem Duitman

  • Esther J. Nossent

  • January 19, 2026

  • 0 min

Share

Clinical Report: A Case Study of Pleuroparenchymal Fibroelastosis

Overview

This report details a case of pleuroparenchymal fibroelastosis (PPFE) without radiological pleural involvement, highlighting the atypical presentation of this rare interstitial lung disease. The patient, a 66-year-old female, exhibited a progressive decline in lung function despite treatment.

Background

Pleuroparenchymal fibroelastosis (PPFE) is a rare interstitial lung disease characterized by excessive elastosis and fibrosis, primarily affecting the pleura and adjacent lung parenchyma. Its atypical presentations, particularly those without overt pleural involvement, complicate diagnosis and management. Understanding PPFE is crucial due to its association with poor prognosis and progressive lung function decline.

Data Highlights

Replace '

No numerical data available.

' with specific numerical data from the case.

Key Findings

  • The patient presented with a persistent non-productive cough and no other respiratory symptoms.
  • Histopathology confirmed an NSIP pattern in the lower lobes and intra-alveolar fibroelastosis in the upper lobes consistent with PPFE.
  • Initial pulmonary function tests showed preserved lung volumes but a decline in diffusion capacity over time.
  • The patient was treated with immunosuppressive therapy, including prednisone and mycophenolate mofetil.
  • Follow-up revealed a progressive pulmonary fibrosis phenotype with declining lung function.

Clinical Implications

Clinicians should be aware of atypical presentations of PPFE, as they may lack classic radiological signs. Early diagnosis and appropriate management are critical to potentially slowing disease progression and improving patient outcomes.

Conclusion

This case underscores the importance of recognizing the heterogeneity of PPFE presentations and the need for a multidisciplinary approach in diagnosis and management.

References

  1. European Radiology, 2024 -- Key Insights on Imaging for Fibrotic Lung Disorders: Guidelines from the European Society of Thoracic Imaging
  2. Clinical Rheumatology, 2023 -- Forecasting the Advancement of Pulmonary Fibrosis in Patients with Interstitial Lung Disease Linked to Anti-Synthetase Syndrome
  3. Infection, 2023 -- Tuberculosis of the Peritoneum
  4. Intensive Care Medicine, 2018 -- Lung Point Observed Without Pneumothorax: A Unique Case Report
  5. Pleuroparenchymal Fibroelastosis: Update on CT and Histologic Findings, 2023
  6. American Journal of Respiratory and Critical Care Medicine, 2022 -- Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
  7. Pleuroparenchymal fibroelastosis: review of 81 cases, 2023
  8. Pleuroparenchymal Fibroelastosis: Update on CT and Histologic Findings - PubMed
  9. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline | American Journal of Respiratory and Critical Care Medicine
  10. Pleuroparenchymal fibroelastosis: review of 81 cases - PubMed

Original Source(s)

Related Content